P22 viral capsids as nanocomposite high-relaxivity MRI contrast agents - Wikidata - wikimedia - TriplyDB

P22 viral capsids as nanocomposite high-relaxivity MRI contrast agents

P22 viral capsids as nanocomposite high-relaxivity MRI contrast agents

http://www.wikidata.org/entity/Q34289410

about

Bacteriophage lambda: Early pioneer and still relevant Metalloprotein-based MRI probes Lanthanide probes for bioresponsive imaging Virus-Based Nanoparticles as Versatile Nanomachines Virus-based nanomaterials as positron emission tomography and magnetic resonance contrast agents: from technology development to translational medicine Ln[DO3A-N-α-(pyrenebutanamido)propionate] complexes: optimized relaxivity and NIR optical properties.Manganese(III) porphyrins complexed with P22 virus-like particles as T1-enhanced contrast agents for magnetic resonance imaging.Understanding the enormous diversity of bacteriophages: the tailed phages that infect the bacterial family Enterobacteriaceae Lumazine Synthase Protein Nanoparticle-Gd(III)-DOTA Conjugate as a T1 contrast agent for high-field MRI Silica-coated Gd(DOTA)-loaded protein nanoparticles enable magnetic resonance imaging of macrophages.Cargo-shell and cargo-cargo couplings govern the mechanics of artificially loaded virus-derived cages.Design of virus-based nanomaterials for medicine, biotechnology, and energy.Fabrication of nanoarchitectures templated by virus-based nanoparticles: strategies and applications.Engineering Gd-loaded nanoparticles to enhance MRI sensitivity via T(1) shortening.Production and applications of engineered viral capsids.Exploitation of viral properties for intracellular delivery.Viral chemistry: the chemical functionalization of viral architectures to create new technology.Viruses, Artificial Viruses and Virus-Based Structures for Biomedical Applications.Click Chemistry in the Development of Contrast Agents for Magnetic Resonance Imaging.Viral nanoparticles decorated with novel EGFL7 ligands enable intravital imaging of tumor neovasculature.Dual Functionalized Bacteriophage Qβ as a Photocaged Drug Carrier.Engineering nanocages with polyglutamate domains for coupling to hydroxyapatite biomaterials and allograft bone.Formation mechanism of chalcogenide nanocrystals confined inside genetically engineered virus-like particles.P22 virus-like particles constructed Au/CdS plasmonic photocatalytic nanostructures for enhanced photoactivity.Gadolinium-Loaded Viral Capsids as Magnetic Resonance Imaging Contrast Agents.Nitroxyl Modified Tobacco Mosaic Virus as a Metal-Free High-Relaxivity MRI and EPR Active Superoxide Sensor Application of Plant Viruses as a Biotemplate for Nanomaterial Fabrication

P2860

Q26830795-D4DF3766-F3E2-42F0-B379-458DB0D01050 Q26849668-7B801E4C-9430-4E7E-A5EC-ADEB35AD0D8B Q27000361-321260FD-A2DF-4AB1-9876-E33A17445357 Q28068538-423756CA-29FC-4ADD-8734-03184B63F2A8 Q28550482-CCB355C1-C7AC-4D6F-8749-394E665F61E2 Q30716845-48A12437-A3BD-49F3-B557-979C45F9504E Q30722696-B4584577-4717-43FC-A48A-AADCFAD662FB Q34995724-A82C5ABD-2930-45DA-B876-1AE706A81D96 Q36192560-1B6CA66F-D969-43E6-A5A3-BE1561E3C675 Q36361995-76642ABF-334F-42EB-86F8-6DDFD77575DE Q36884237-30E66DA3-92CC-4D41-9D6A-31C740114A7C Q37346447-9243DF3B-1B13-49CB-9A97-39F7A9193F96 Q38133463-5F91A1A7-4F23-427D-AF93-280E8E15BD7D Q38155457-CA997707-68EA-4BE5-86FA-E4E15BA64EB4 Q38210894-45D02702-0E29-402F-A45B-E213B17604CF Q38216947-C54EA6BD-0465-4E6D-B1D1-72A124D27974 Q38668484-D4D66AC0-05CC-4070-B62A-366C1258FA1C Q38818912-27139713-F5F9-4E91-A653-2935227CBCF0 Q38982559-C1ED8A03-7BB6-4F0D-BA60-7C18BA65BD50 Q40086225-CF298461-3BB2-47FC-BDB2-02664A4BE23A Q40678773-9E2534A1-0C47-4F04-80B8-5EC2F5930191 Q41875872-13B54CA1-D6E4-4317-BB56-161FAADC0159 Q41886713-DA9F1B08-DE4E-4E21-A099-82ECC24151E5 Q42179955-266EF01F-BE2D-49C9-AB06-3C3B9E79AF44 Q42379549-AD6FC0C7-561D-41EE-87B2-188E5BDBE125 Q57585475-10400B29-5C89-4273-9859-AB3F8DD1A72F Q58696447-F3BEE991-9BFD-46F2-A8FD-0920F394DAC9

P2860

P22 viral capsids as nanocomposite high-relaxivity MRI contrast agents

http://www.wikidata.org/entity/Q34289410

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

P22 viral capsids as nanocomposite high-relaxivity MRI contrast agents

@ast

P22 viral capsids as nanocomposite high-relaxivity MRI contrast agents

@en

P22 viral capsids as nanocomposite high-relaxivity MRI contrast agents

@nl

type

label

P22 viral capsids as nanocomposite high-relaxivity MRI contrast agents

@ast

P22 viral capsids as nanocomposite high-relaxivity MRI contrast agents

@en

P22 viral capsids as nanocomposite high-relaxivity MRI contrast agents

@nl

prefLabel

P22 viral capsids as nanocomposite high-relaxivity MRI contrast agents

@ast

P22 viral capsids as nanocomposite high-relaxivity MRI contrast agents

@en

P22 viral capsids as nanocomposite high-relaxivity MRI contrast agents

@nl

P1433

Q34289410-ACDE1130-523A-4989-9860-BDE85B5B17BF

P1476

Q34289410-32FC37D2-655B-4A3D-93AE-4B94EBD13B96

P2093

Q34289410-3805C7AE-AFFF-4FEE-AA11-08588D9272A5

Q34289410-6E8A025A-3155-4B1D-A36F-D08F42AEE359

Q34289410-A6E686F5-DB24-4D3E-83B9-8872A7EE4F36

Q34289410-C1AEE9E9-03B7-4EE4-B6AB-19F2593B8BC1

Q34289410-DF91685E-982A-4A6D-9ABD-3A326F939098

Q34289410-E27477E9-0897-4B0E-AA58-F4E4E0CA92E8

Q34289410-E375BC9B-F874-4153-A406-AD95C9E68CB6

P2860

Q34289410-015983A5-3093-4504-83F1-07B1384CD1F8

Q34289410-1AB25142-F618-4397-BA57-DD800D7EB3C9

Q34289410-2100177A-67E0-4638-AD3D-0D12213501DE

Q34289410-216C3A20-4D2A-422E-93F1-690AEEF5E223

Q34289410-3B11AF10-0F0F-4A68-843B-D307C1D9146E

Q34289410-3F42ADBF-AFA7-4E50-902B-C792220E6314

Q34289410-4DCE045B-E4E1-45B0-AA70-F49CDEE00BCC

Q34289410-53F4B5EC-CCEE-49F6-AD3F-D00EA2B72B48

Q34289410-54393563-13A5-47C6-BD0C-BCEB84B9E345

Q34289410-62469748-2571-499E-8010-B290931C4D72

P304

Q34289410-BD22A04C-2B6C-4188-88A4-A6AC1D903B52

P31

Q34289410-66EA422E-4D95-4D85-B926-4BA49F79D578

P356

Q34289410-A8CEC1C7-7352-40E4-BCBB-CB540C43BCFD

P407

Q34289410-B3CA4B0D-7BC0-41B5-BFC3-0CBEA40CE8F3

P433

Q34289410-332E86B4-3415-4E1B-B3D3-A0FE50078932

P478

Q34289410-53F75204-52E5-41D2-9DA1-5B920DEE3AD3

P577

Q34289410-04E52B79-7038-4939-B2F4-0F75226A61EA

P5875

Q34289410-2689B76F-2F38-4842-9D5C-302D265250FF

P698

Q34289410-89302B25-9B1A-4E9D-A1EF-01733D1FC119

P921

Q34289410-AD5DA126-2E6F-4F3A-A715-8DF42A1404DD

P932

Q34289410-ECD42E07-07C6-4988-B935-55E00E5D815B

P356

P1433

Molecular Pharmaceutics

P1476

P22 viral capsids as nanocomposite high-relaxivity MRI contrast agents

@en

P2093

Ben Johnson

http://www.w3.org/2001/XMLSchema#string

Joseph A Frank

http://www.w3.org/2001/XMLSchema#string

Lars O Liepold

http://www.w3.org/2001/XMLSchema#string

Md Joynal Abedin

http://www.w3.org/2001/XMLSchema#string

Peter Prevelige

http://www.w3.org/2001/XMLSchema#string

Shefah Qazi

http://www.w3.org/2001/XMLSchema#string

Trevor Douglas

http://www.w3.org/2001/XMLSchema#string

P2860

P22 Coat Protein Structures Reveal a Novel Mechanism for Capsid Maturation: Stability without Auxiliary Proteins or Chemical Crosslinks

Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents.

Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging.

Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.

High relaxivity gadolinium hydroxypyridonate-viral capsid conjugates: nanosized MRI contrast agents.

Magnetic resonance contrast agents from viral capsid shells: a comparison of exterior and interior cargo strategies.

Supramolecular protein cage composite MR contrast agents with extremely efficient relaxivity properties.

Macromolecular and dendrimer-based magnetic resonance contrast agents.

Viral nanoparticles as platforms for next-generation therapeutics and imaging devices

Penton release from P22 heat-expanded capsids suggests importance of stabilizing penton-hexon interactions during capsid maturation.

P304

11-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/MP300208G

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225093766

http://www.w3.org/2001/XMLSchema#string

P698

22656692

http://www.w3.org/2001/XMLSchema#string

P921

P932

3707300

http://www.w3.org/2001/XMLSchema#string